Litcius/Paper detail

Stigmatizing comments about medication can derail treatment

Gary Enos

2021Alcoholism & Drug Abuse Weekly14 citationsDOI

Abstract

Stigmatizing comments from a loved one about methadone or buprenorphine treatment, based on prevalent misinformation, can deeply sting for a person with opioid use disorder (OUD) who is relying on one of the medications as a component of recovery. As a new study featuring data from interviews with 52 treatment patients suggests, these comments often have harmful consequences for treatment, derailing disclosers' progress and placing them at serious risk.

Topics & Concepts

MisinformationBuprenorphineOpioid use disorderPsychiatryMethadonePsychologyMethadone maintenanceMedicinePsychotherapistOpioidComputer securityComputer scienceInternal medicineReceptorSubstance Abuse Treatment and OutcomesOpioid Use Disorder TreatmentDigital Mental Health Interventions